https://www.marketscreener.com/quote/stock/ASTRAZENECA-PLC-4000930/news/Eplontersen-Met-Co-Primary-and-Secondary-Endpoints-in-Interim-Analysis-of-the-NEURO-TTRansform-Phase-40775309/?utm_source=telegram&utm_medium=social&utm_campaign=share